Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/mlab · Entity 5221 | CSMO | March 26, 2018 | March 26, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date March 26, 2018 · Filed March 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $70.56 · Expires 2021-04-01 | Direct | 20,838 |
Reported balance
After 2018-03-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-26 · Other · Disposed 3,300 · Balance 20,838 F1: Performance based non-qualified stock options that failed to vest based on performance criteria. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance based non-qualified stock options that failed to vest based on performance criteria.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2018 Filed Mar 26, 2018 14:43 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherNon-qualified stock option · Derivative | 3,300 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-18-000009 · primary_doc.xml · derivative · entry 1 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,838 Underlying: Common Stock · 3,300 shares Expires 2021-04-01 F1 · shares: Performance based non-qualified stock options that failed to vest based on performance criteria. Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 20:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 4,000 | $148.98 | $595,920.00 |
DisclosureSEC source: 0001228924-17-000027 · primary_doc.xml · nonDerivative · entry 1 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:13 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 3,500 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-17-000017 · primary_doc.xml · derivative · entry 1 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,138 Underlying: Common Stock · 3,500 shares Expires 2023-04-03 F1 · derivative.exercise_date: 20% exercisable on each of first 5 anniversary dates Read SEC document |
| February 07, 2017 Filed Feb 7, 2017 22:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 2,625 | $123.12 | $323,190.00 |
DisclosureSEC source: 0001228924-17-000001 · primary_doc.xml · nonDerivative · entry 4 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,100 Read SEC document |
| February 07, 2017 Filed Feb 7, 2017 22:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 1,070 | $121.65 | $130,165.50 |
DisclosureSEC source: 0001228924-17-000001 · primary_doc.xml · nonDerivative · entry 2 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,100 Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 22:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherIncentive Stock Option · Derivative | 199 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-17-000001 · primary_doc.xml · derivative · entry 6 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,638 Underlying: Common Stock · 199 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 22:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 871 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-17-000001 · primary_doc.xml · derivative · entry 5 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,837 Underlying: Common Stock · 871 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 22:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 4,375 | $125.38 | $548,537.50 |
DisclosureSEC source: 0001228924-17-000001 · primary_doc.xml · nonDerivative · entry 3 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,725 Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 22:50 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | Exercise / conversionCommon Stock | 1,070 | $70.56 | $75,499.20 |
DisclosureSEC source: 0001228924-17-000001 · primary_doc.xml · nonDerivative · entry 1 Adriance Glenn E · CIK 0001431535 · CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherIncentive Stock Option · Derivative | 314 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-16-000050 · primary_doc.xml · derivative · entry 6 Adriance Glenn E · CIK 0001431535 · CMSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,708 Underlying: Common Stock · 314 shares Expires 2022-04-01 F2 · derivative.exercise_date: 1/7 exercisable on each anniversary date Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,828 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-16-000050 · primary_doc.xml · derivative · entry 5 Adriance Glenn E · CIK 0001431535 · CMSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,022 Underlying: Common Stock · 1,828 shares Expires 2022-04-01 F2 · derivative.exercise_date: 1/7 exercisable on each anniversary date Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,425 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0001228924-16-000050 · primary_doc.xml · derivative · entry 4 Adriance Glenn E · CIK 0001431535 · CMSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,850 Underlying: Common Stock · 1,425 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/4 exercisable each anniversary date Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,567 | $135.93 | $484,862.31 |
DisclosureSEC source: 0001228924-16-000050 · primary_doc.xml · nonDerivative · entry 3 Adriance Glenn E · CIK 0001431535 · CMSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,100 Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 2,142 | $89.70 | $192,137.40 |
DisclosureSEC source: 0001228924-16-000050 · primary_doc.xml · nonDerivative · entry 2 Adriance Glenn E · CIK 0001431535 · CMSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,425 | $51.85 | $73,886.25 |
DisclosureSEC source: 0001228924-16-000050 · primary_doc.xml · nonDerivative · entry 1 Adriance Glenn E · CIK 0001431535 · CMSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.